ReviewArthritis research & therapy2012

Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity.

Henrik E Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.